Open AccessChemoembolization alonevscombined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients
Author(s) -
Song Gao,
Pengjun Zhang,
Jun Guo,
Hui Chen,
Haifeng Xu,
Peng Liu,
Renjie Yang,
Xu Zhu
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i36.10443
Subject(s) - medicine , hepatocellular carcinoma , oxaliplatin , folinic acid , gastroenterology , chemotherapy , transcatheter arterial chemoembolization , fluorouracil , adverse effect , significant difference , surgery , cancer , colorectal cancer
To compare the efficacy and safety of chemoembolization alone or chemoembolization combined with hepatic arterial infusion chemotherapy (HAIC), including oxaliplatin (OXA), 5-fluorouracil (5-FU) and folinic acid (CF), in inoperable hepatocellular carcinoma (HCC) without distant metastasis.